Cargando…

Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action

Repurposed drugs that are safe and immediately available constitute a first line of defense against new viral infections. Despite limited antiviral activity against SARS-CoV-2, several drugs are being tested as medication or as prophylaxis to prevent infection. Using a stochastic model of early phas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czuppon, Peter, Débarre, Florence, Gonçalves, Antonio, Tenaillon, Olivier, Perelson, Alan S., Guedj, Jérémie, Blanquart, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951973/ https://www.ncbi.nlm.nih.gov/pubmed/33647008 http://dx.doi.org/10.1371/journal.pcbi.1008752

Ejemplares similares

A stochastic analysis of the interplay between antibiotic dose, mode of action, and bacterial competition in the evolution of antibiotic resistance
por: Czuppon, Peter, et al.
Publicado: (2023)

The stochastic dynamics of early epidemics: probability of establishment, initial growth rate, and infection cluster size at first detection
por: Czuppon, Peter, et al.
Publicado: (2021)

Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load
por: Gonçalves, Antonio, et al.
Publicado: (2020)

Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants
por: Blanquart, François, et al.
Publicado: (2022)

Factors favouring the evolution of multidrug resistance in bacteria
por: Jacopin, Eliott, et al.
Publicado: (2020)

Characterisation of vaccine breakthrough infections of SARS-CoV-2 Delta and Alpha variants and within-host viral load dynamics in the community, France, June to July 2021
por: Blanquart, François, et al.
Publicado: (2021)

Quantifying the relationship between SARS-CoV-2 viral load and infectiousness
por: Marc, Aurélien, et al.
Publicado: (2021)

A New Age-Structured Multiscale Model of the Hepatitis C Virus Life-Cycle During Infection and Therapy With Direct-Acting Antiviral Agents
por: Quintela, Barbara de M., et al.
Publicado: (2018)

Zika virus dynamics: Effects of inoculum dose, the innate immune response and viral interference
por: Best, Katharine, et al.
Publicado: (2021)

Temporal, age, and geographical variation in vaccine efficacy against infection by the Delta and Omicron variants in the community in France, December 2021 to March 2022
por: Blanquart, François, et al.
Publicado: (2023)

Analysis of Hepatitis C Virus Decline during Treatment with the Protease Inhibitor Danoprevir Using a Multiscale Model
por: Rong, Libin, et al.
Publicado: (2013)

The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics?
por: Nguyen, Thi Huyen Tram, et al.
Publicado: (2017)

Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
por: Driouich, Jean-Sélim, et al.
Publicado: (2021)

Estimating the global reduction in transmission and rise in detection capacity of the novel coronavirus SARS-CoV-2 in early 2020
por: Belloir, Antoine, et al.
Publicado: (2021)

Clinical trial simulation to evaluate power to compare the antiviral effectiveness of two hepatitis C protease inhibitors using nonlinear mixed effect models: a viral kinetic approach
por: Laouénan, Cédric, et al.
Publicado: (2013)

An explanation for SARS-CoV-2 rebound after Paxlovid treatment
por: Perelson, Alan S., et al.
Publicado: (2023)

Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates
por: Marlin, Romain, et al.
Publicado: (2022)

Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One + zero equals two?
por: Eloy, Philippine, et al.
Publicado: (2021)

Within-host models of SARS-CoV-2: What can it teach us on the biological factors driving virus pathogenesis and transmission?
por: Prague, Mélanie, et al.
Publicado: (2022)

Modeling Within-Host Dynamics of SARS-CoV-2 Infection: A Case Study in Ferrets
por: Vaidya, Naveen K., et al.
Publicado: (2021)

Synthesis and Evaluation of 9-Aminoacridines with SARS-CoV-2 Antiviral Activity
por: Jones, Thane, et al.
Publicado: (2023)

Higher-dimensional algebraic geometry
por: Debarre, Olivier
Publicado: (2001)

Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir
por: Moreno, Santiago, et al.
Publicado: (2022)

High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort
por: Tubiana, Sarah, et al.
Publicado: (2021)

Computational modeling of the pharmacological actions of some antiviral agents against SARS-CoV-2
por: Adegboyega, Abayomi Emmanuel, et al.
Publicado: (2021)

Modeling the bacterial dynamics in the gut microbiota following an antibiotic‐induced perturbation
por: Guk, Jinju, et al.
Publicado: (2022)

Agent-based modeling of host–pathogen systems: The successes and challenges
por: Bauer, Amy L., et al.
Publicado: (2009)

Innate immune-mediated antiviral response to SARS-CoV-2 and convalescent sera a potential prophylactic and therapeutic agent to tackle COVID-19
por: Abdullah,, et al.
Publicado: (2020)

Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2
por: Clairon, Quentin, et al.
Publicado: (2023)

Preventive and Prophylactic Mechanisms of Action of Pomegranate Bioactive Constituents
por: Viladomiu, Monica, et al.
Publicado: (2013)

Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19
por: Thimmulappa, Rajesh K., et al.
Publicado: (2021)

Determining Ribavirin’s mechanism of action against Lassa virus infection
por: Carrillo-Bustamante, Paola, et al.
Publicado: (2017)

Evolutionary Epidemiology of Drug-Resistance in Space
por: Débarre, Florence, et al.
Publicado: (2009)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

In vivo kinetics of SARS-CoV-2 infection and its relationship with a person’s infectiousness
por: Ke, Ruian, et al.
Publicado: (2021)

In vivo kinetics of SARS-CoV-2 infection and its relationship with a person’s infectiousness
por: Ke, Ruian, et al.
Publicado: (2021)

Published Anti-SARS-CoV-2 In Vitro Hits Share Common Mechanisms of Action that Synergize with Antivirals
por: Xing, Jing, et al.
Publicado: (2021)

Published anti-SARS-CoV-2 in vitro hits share common mechanisms of action that synergize with antivirals
por: Xing, Jing, et al.
Publicado: (2021)

Anurans against SARS-CoV-2: A review of the potential antiviral action of anurans cutaneous peptides
por: de Amaral, Marjoriane, et al.
Publicado: (2022)

Unique Mode of Antiviral Action of a Marine Alkaloid against Ebola Virus and SARS-CoV-2
por: Izumida, Mai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_42f2rt331h9kjmlgco2t5evhra